GEN Exclusives

More »

GEN News Highlights

More »
Jul 9, 2007

Pluristem and German Center for Regenerative Therapies Ink Research Deal

  • Pluristem Life Systems inked a research agreement with the Berlin-Brandenburg Center for Regenerative Therapy (BCRT) at Charité-University Medicine Berlin. Pluristem and BCRT will explore a variety of indications utilizing mesenchymal stem cells (MSCs) derived from the placenta that have been expanded in the company’s PluriX™ 3-D bioreactor.

    The initial focus of the alliance will be on neurological indications such as multiple sclerosis and Parkinson’s disease. The agreement also covers organ transplantation and cardiovascular indications like inflammatory cardiomyopathy. Pluristem will be the exclusive owner of the technology and any products stemming from the collaboration.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?